Introduction
Cell death via apoptosis plays an important role in maintaining apoptosis and respond to antigen receptor cross-linking as a activation signal (4-9). These B cells are useful models for the size and composition of lymphocyte populations. Selfreactive B lymphocytes are eliminated by apoptosis in the studying mechanisms of immune tolerance and the development of autoimmunity. bone marrow and the germinal centers of peripheral lymphoid organs (1) (2) (3) . A breakdown of immune tolerance to selfUnlike vertebrate DNA, bacterial DNA induces polyclonal B cell proliferation and Ig secretion (10). Recent studies antigen is thought to promote the development of autoimmune diseases such as systemic lupus erythematosus (SLE) .
have demonstrated that unmethylated CpG dinucleotides in particular sequence contexts (CpG motifs) in bacterial DNA WEHI-231 B lymphoma cells, which have some characteristics of immature B cells, undergo growth arrest and apoptosis in are responsible for the bacterial DNA-mediated polyclonal B cell activation (11). In addition to their mitogenic effects on B response to cross-linking of their antigen receptor by antiIgM, while splenic mature B cells undergo spontaneous cells, CpG motifs in bacterial DNA or synthetic oligo-nucleotides (CpG DNA) induce secretion of pro-inflammatory (v/v) heat-inactivated FCS (Sigma, St Louis, MO), 1 mM L-glutamine, 1 mM sodium pyruvate, 0.1 mM essential amino cytokines such as tumor necrosis factor (TNF)-α, IL-6, IL-10, and IL-12 from B cells and/or monocytes/macrophages acids, 10 mM HEPES, and 60 µM 2-mercaptoethanol. Murine B lymphoma WEHI-231 (clone 28) and CH31 cells were (11-17). CpG DNA also synergizes with antigen receptormediated signals leading to TNF-α, IL-6 and Ig production, kindly provided by Dr David Scott (American Red Cross, Rockville, MD). WEHI-231 and CH31 cells were maintained and B cell proliferation, indicating its function as a costimulatory factor in the presence of specific antigen (11,12, in RPMI 1640 supplemented with 10% FCS, 1.5 mM Lglutamine, 50 µM 2-mercaptoethanol, 100 U/ml penicillin and and A.-K. Yi and A. M. Krieg, unpublished data). CpG DNA activates NK cells to secrete IFN-γ, promotes cytotoxic 100 µg/ml streptomycin. All cells were cultured at 37°C in a 5% CO 2 humidified incubator. activities of NK cells and enhances the efficacy of mAb therapy for lymphoma (15, 16, 18) . CpG DNA protects mice from eosinophilic airways inflammation (asthma) and it is also
Oligodeoxynucleotides (ODN) a very effective vaccine adjuvant (19) (20) (21) (22) (23) (24) . While it has these Nuclease resistant phosphorothioate ODN (S-ODN) were very beneficial effects as a therapeutic agent, CpG DNA also purchased from Oligos Etc. (Wilsonville, OR). All ODN were can mediate some unwanted effects. In experimental models, purified by ethanol precipitation as described (12) using CpG DNA contributes to septic shock-like syndrome (15,25).
pyrogen-free solutions and had undetectable endotoxin by In addition, CpG DNA rescues mature splenic B cells from
Limulus assay (QCL-1000; BioWhittaker, Walkersville, MD) spontaneous apoptosis and WEHI-231 cells from antigen following the manufacturer's protocol. S-ODN 1826 (TCCATreceptor-mediated apoptosis (9, 26, 27) . The molecular GACGTTCCTGACGTT) was used as a CpG DNA, and Smechanisms of these effects have been unclear, although ODN 1745 (TCCATGAGCTTCCTGAGTCT), 1911 (TCCAGGwe have recently demonstrated a possible role for reactive ACTTTCCTCAGGTT) and 1982 (TCCAGGACTTCTCTCAGoxygen species (ROS) and NFκB activation in mediating the GTT) were used as control non-CpG DNA. Note 1 µM of CpG anti-apoptotic effects of CpG DNA in WEHI-231 cells (27) .
or non-CpG DNA equals 6 µg/ml. The antimalarial drug chloroquine is widely used in the treatment of SLE and rheumatoid arthritis. However, its mechReagents anism of action is incompletely understood. We and others have recently reported that chloroquine inhibits certain of Goat polyclonal anti-mouse IgM (µ chain specific) was purchased from Sigma, and used at 1-10 µg/ml to induce growth the immune stimulatory effects of CpG DNA, including the induction of cytokine expression and protection against inhibition and apoptosis in WEHI-231 cells. Anti-murine CD40 antibody was purchased from PharMingen (San Diego, CA) activation-induced apoptosis in WEHI-231 cells (28, 29) . In this connection, we evaluated the mechanism through which and used at 1-2 µg/ml. LPS and chloroquine were purchased from Sigma. chloroquine interferes with the anti-apoptotic effects of CpG DNA in WEHI-231 cells and primary splenic B cells. Here, we demonstrate that low concentrations of chloroquine (Ͻ5 µM)
Cell proliferation assay effectively and specifically inhibit the ability of CpG DNA to Mouse splenic B cells (5ϫ10 4 cells/100 µl/well) or WEHI-231 rescue WEHI-231 cells from activation-induced apoptosis and cells (2ϫ10 4 cells/100 µl/well) were treated with medium or splenic mature B cells from spontaneous apoptosis. The chloroquine (0.5-2.5 µg/ml) for 1 h. Then cells were cultured protective effects of CpG DNA in these two systems are in medium alone, anti-CD40 (1-2 µg/ml), LPS (10 µg/ml), CpG linked to the maintenance of the mitochondrial membrane DNA (0.1-0.5 µM) or non-CpG DNA (0.1-0.5 µM) in the potential (ψm) and the nuclear translocation of NFκB, and presence or absence of anti-IgM (2 µg/ml). Cells were subsequent proto-oncogene and oncoprotein expression in incubated at 37°C for 24 h with a last 4 h pulse with 1 µCi/ these cells. Chloroquine specifically blocks all of these effects well of [ 3 H]thymidine. Cells were harvested using semiof CpG DNA, but does not block the effects of anti-CD40, antiautomatic cell harvester (Skatron, Sterling, VA) and radioIgM or lipopolysaccharide (LPS). These chloroquine effects activity was counted by scintillation counter (Packard, could potentially restore apoptotic susceptibility to selfMeriden, CT). reactive B cells protected by bacterial DNA.
Propidium iodide (PI) staining for hypodiploid nuclei and FACS analysis Methods
For the induction of apoptosis, WEHI-231 B lymphoma cells Mice, cell lines and culture conditions (5ϫ10 5 cells/ml) were treated with medium or chloroquine (2.5 µg/ml) for 1 h. Then cells were stimulated with medium, B 6 D 2 F 1 specific pathogen-free mice at 8-18 weeks of age were obtained from the Jackson Laboratory (Bar Harbor, ME)
anti-CD40 (1 µg/ml), CpG DNA (0.5 µM) or non-CpG DNA (0.5 µM) in the presence or absence of anti-IgM (1 µg/ml) for and maintained under specific pathogen-free conditions in the University of Iowa animal care unit. Splenic B lymphocytes 48 h. The presence of apoptotic nuclei was analyzed after PI staining as previously described (26). The cells were analyzed were obtained from B 6 D 2 F 1 spleens by the BSA panning method as described previously (6) . Cells obtained in this by FACScan (linear scale; Becton Dickinson, San Jose, CA). Apoptotic cells were identified by having less than diploid manner were 97% surface Ig ϩ B220 ϩ . Splenic B lymphocytes were either assayed directly (0 h) or placed in culture in RPMI DNA content (hypodiploid nuclei). All FACScan data analysis was performed using Lysys II software (Becton Dickinson). 1640 (Gibco/BRL, Gaithersburg, MD) supplemented with 5%
Simultaneous analysis of cell cycle and apoptosis by acridine 2, bax and L32 mRNA were detected using the RPA as previously described (31) . Equivalent amounts of RNA were orange (AO) examined, as judged by the amount of L32, which encodes Because the fluorescent dye AO (Polysciences, Warrington, a ubiquitously expressed ribosome subunit protein (32) , in PA) can stain double-stranded DNA and single-stranded RNA each sample. The GenBank accession numbers and nucleometa-chromatically, the percent of cells which are in G 0 , G 1 , tide sequences for those genes were previously reported (26). S/G 2 /M and apoptosis can be determined (30) . Cell cycle and apoptosis were analyzed simultaneously by AO staining as Western blot analysis previously described (8). Briefly, splenic B cells (1.15ϫ10 6 / Splenic B cells (1.15ϫ10 6 cells/ml) were stimulated for 6 h ml) were stimulated with medium, CpG DNA (0.05-0.1 µM), with medium, CpG DNA (0.05 µM), non-CpG DNA (0.05 non-CpG DNA (0.05-0.1 µM), LPS (1 µg/ml) or anti-CD40 µM) or anti-CD40 (1 µg/ml) in the presence or absence of (1 µg/ml) in the presence or absence of various concentrations chloroquine (1 µg/ml) and washed 3 times with ice-cold PBS. (0-1 µg/ml) of chloroquine. After 16 h incubation, cells were Whole-cell lysates were prepared as previously described permeabilized in a buffer containing 0.1% sodium citrate, (26). Equal concentrations of cell lysates (25 µg/lane) were 0.02 M sodium phosphate, 0.1% Triton X-100, 0.2 M sucrose boiled in SDS sample buffer for 4 min before being subjected and 0.1 mM disodium EDTA at pH 3.5. After 1 min cells were to electrophoresis on a 10% polyacrylamide gel containing stained by the addition of an equal amount of buffer containing 0.1% SDS (SDS-PAGE). After electrophoresis, proteins were 20 µg/ml of AO, 0.01 M sodium phosphate and 0.1 M NaCl transferred to Immobilon-P transfer membranes (Millipore, at pH 3. , anti-CD40 (1 µg/ml) and/or anti-IgM (10 µg/ml) in the presence or absence of chloroquine (1-2.5 µg/ml). Cells Splenic B cells (1.15ϫ10 6 cells/ml) were stimulated with were harvested and nuclear extracts were prepared as previmedium, CpG DNA (0.05 µM), non-CpG DNA (0.05 µM), LPS ously described (27) . EMSA was done as described previously (2 µg/ml) or anti-CD40 (1 µg/ml) in the presence or absence (27) using 32 P-labeled oligonucleotides containing the κB of chloroquine (1 µg/ml for splenic B cells) for 4-40 h. Cells sequence from κ-intronic enhancer (5Ј-GTAGGGGACTTwere washed twice with PBS, and then aliquoted for Annexin TCCGAGCTCGAGATCCTATG-3Ј) (33) 
cells from anti-IgM-induced growth arrest and apoptosis Preparation of RNA and RNase protection assay (RPA)
Anti-IgM-treated WEHI-231 cells were stimulated with CpG DNA in the presence or absence of low doses (Ͻ5 µM) of WEHI-231 cells (2ϫ10 6 cells/ml) were pre-treated with medium or chloroquine (2.5 µg/ml) for 30 min. Cells were then treated chloroquine, shown to be effective in our preliminary studies. As expected (26), cross-linking of the B cell receptor on with medium, CpG or non-CpG DNA (0.5 µM), or anti-CD40 (1 µg/ml) in the presence or absence of anti-IgM (10 µg/ml).
WEHI-231 cells induced growth arrest (Fig. 1 ). Both CpG DNA and anti-CD40 protected WEHI-231 cells from anti-IgMCells were harvested 9 h after DNA treatments and total RNA was isolated by using RNAzol B (Tel-Test, Friendswood, TX) induced growth arrest but control non-CpG DNA did not (data not shown). Addition of chloroquine abolished CpG DNAfollowing the manufacturer's protocol. The c-myc, c-fos, cmyb, myn, egr-1, c-jun, c-Ki-ras, fas ligand, fas, bcl-x L , bclmediated protection against anti-IgM-induced growth arrest WEHI-231 B cells (5ϫ10 5 cells/ml) were pretreated for 30 min with chloroquine (2.5 µg/ml) or with regular medium. Cells were treated with medium, anti-IgM (10 µg/ml), or the combination of anti-IgM and CpG DNA 1826 (0.5 µM), non-CpG DNA 1911 (0.5 µM) or anti-CD40 (1 µg/ml) for 40 h. The presence of hypodiploid nuclei as an indication of apoptotic cell was analyzed by PI staining and flow cytometry as described (26). The percentage apoptotic cells is indicated as a number in the table. ND indicates not done. The experiment was repeated Ͼ3 times with WEHI-231 and CH31 cells with similar results. of WEHI-231 cells, but failed to prevent anti-CD40-mediated protection (Fig. 1 ). Since growth inhibition does not always correlate with different between these cell types. Therefore, we evaluated whether CpG DNA-mediated cell cycle entry and/or protection apoptosis, we also determined the effect of CpG DNA on anti-IgM-induced hypodiploid nuclei generation, a reliable against spontaneous apoptosis of splenic B cells is also sensitive to chloroquine. As demonstrated in Fig. 2 , anti-CD40, marker for apoptosis (26) . Approximately 50% of WEHI-231 cells are undergoing apoptosis at 48 h after anti-IgM treatment LPS or CpG DNA rescued splenic B cells from spontaneous apoptosis. Very low concentrations of chloroquine (ഛ1 µg/ml) ( Table 1 ) (26). Like anti-CD40, CpG DNA protected WEHI-231 cells from anti-IgM-mediated apoptosis while control nonefficiently blocked CpG DNA-mediated protection against spontaneous apoptosis of splenic B cells ( Fig. 2A) . Moreover, CpG DNA failed to rescue WEHI-231 cells (Table 1) (26,27 ). However, as demonstrated in Table 1 , CpG DNA failed to CpG DNA-induced cell cycle entry of splenic B cells was also completely inhibited by the same concentrations of protect WEHI-231 cells from anti-IgM-induced apoptosis in the presence of chloroquine. In contrast, chloroquine showed chloroquine (Fig. 2B) . The inhibitory effects of chloroquine were dose dependent. In contrast, neither the mitogenic no effect on anti-CD40-mediated rescue of WEHI-231 cell apoptosis. These results indicate that CpG DNA protects nor the anti-apoptotic effects of LPS or anti-CD40 were suppressed by chloroquine under these conditions (Figs. 2A WEHI-231 B cells from anti-IgM-induced growth arrest and apoptosis through a chloroquine-sensitive pathway. and 2B).
CpG DNA prevents the loss of mitochondrial membrane CpG DNA-mediated splenic B cell proliferation and rescue of spontaneous apoptosis of splenic B cells are inhibited by low potential (ψm) through a chloroquine-sensitive pathway concentrations of chloroquine
In many models of apoptosis induction, loss of the ψm takes place at an early stage in the apoptotic cascade (34) . We CpG DNA protects primary splenic B cells from spontaneous apoptosis and induces their proliferation (9,11,12). The pathinvestigated whether ψm is reduced during the process of spontaneous apoptosis of splenic B cells and whether CpG ways which lead to spontaneous apoptosis of primary splenic B cells and activation-induced apoptosis of WEHI-231 cells DNA prevents ψm disruption (∆ψm) through a chloroquinesensitive pathway. Primary splenic B cells were cultured could be different, and the mechanisms by which CpG DNA induces cell proliferation or blocks apoptosis also could be with or without CpG DNA in the presence or absence of c-Myc and Bcl-2 were constitutively expressed in freshly isolated splenic B cells (T0 in Fig. 4 ). The levels of c-Myc protein gradually decreased after onset of the culture, but the levels of Bcl-2 protein were maintained throughout the culture period (T16 in Fig. 4 ). The expression of c-Myc protein chloroquine. ∆ψm and plasma membrane transition were was induced and maintained for at least 16 h in the presence measured using DiOC 6 (3) and Annexin V staining respectively.
of CpG DNA or anti-CD40 in splenic B cells. Anti-CD40 As shown in Fig. 3 , loss of ψm was detected within 4 h and induced expression of Bcl-x L and c-Jun proteins within 6 h increased through 40 h after initiation of the culture (compare but c-Jun protein was undetectable by 16 h after initiation of fresh cells and column 1) indicating ψm reduction also the culture (Fig. 4 and data not shown). CpG DNA induced occurred during the process of spontaneous apoptosis in expression of Bcl-x L and c-Jun proteins within 6 h, and these splenic B cells. CpG DNA effectively blocked both ψm loss increased protein levels were maintained over 16 h (Fig. 4 and plasma membrane transition (Fig. 3, columns 1 and 3) , and data not shown). However, neither CpG DNA nor antibut neither ψm reduction nor plasma membrane transition CD40 altered the levels of Bcl-2 (Fig. 4) . Interestingly, chlorowas prevented by the addition of control non-CpG DNA (Fig. quine markedly reduced CpG DNA-induced expression of 3, columns 1 and 5). Other anti-apoptotic agents such as c-Myc, c-Jun and Bcl-x L proteins, while it showed no effect anti-CD40 and LPS also inhibited both ψm reduction and on the anti-CD40-induced expression of those oncoproteins plasma membrane transition of splenic B cells (Fig. 3, columns in primary splenic B cells (Fig. 4 and data not shown). 1, 7 and 9). In the presence of chloroquine, CpG DNA failed Chloroquine itself did not alter the levels of these (Fig. 4) . CpG to prevent ψm loss or plasma membrane transition of splenic DNA-mediated, but not anti-CD40-mediated, maintenance of B cells during the process of spontaneous apoptosis (Fig. 3, c-Myc and Bcl-x L protein levels in the presence of anti-IgM columns 1, 3 and 4). In contrast, chloroquine did not block was also abolished by chloroquine in WEHI-231 cells (data anti-CD40- (Fig. 3, columns 7 and 8) or LPS- (Fig. 3, columns not shown). 9 and 10) mediated protection from ψm loss or plasma Chloroquine inhibits CpG DNA-induced expression of protomembrane transition. Neither the ψm loss nor the plasma oncogenes membrane transition in splenic B cells undergoing spontaneous apoptosis was affected by the same concentration of To determine whether the effects of chloroquine on the CpG DNA-induced oncoprotein production occurs at the RNA level, chloroquine (Fig. 3, columns 1 and 2) . the effects of chloroquine on the CpG DNA-mediated protoas a repressor, increased in WEHI-231 cells (Fig. 6A) . Addition of CpG DNA or anti-CD40 maintained the levels of p50/c-Rel oncogene mRNA expression were evaluated. As shown in heterodimer in the presence of anti-IgM in WEHI-231 cells Fig. 5 , the mRNA expression for c-myc, myn, bcl-2 and bax (Fig. 6A) . Pre-treatment with chloroquine selectively inhibited was suppressed in WEHI-231 cells within 9 h of B cell CpG DNA-mediated maintenance of p50/c-Rel heterodimer receptor cross-linking (26). Addition of CpG DNA or antiformation without affecting anti-IgM-induced p50/p50 homo-CD40 prevented anti-IgM-mediated down-regulation of these dimer formation or anti-CD40-mediated NFκB activation in genes in WEHI-231 cells (Fig. 5A and B) . CpG DNA-mediated WEHI-231 cells (Fig. 6A) . preservation of these proto-oncogene mRNA levels was A high level of baseline activation of the transcription abolished by chloroquine, but anti-CD40-mediated expresfactor NFκB was present in freshly prepared (T0) splenic sion of the same proto-oncogenes was not, illustrating the B cells (Fig. 6B ) (36) (37) (38) . The levels of nuclear NFκB in selective effect of this drug on the CpG DNA-mediated splenic B cells gradually declined after initiation of culture signaling pathway. Chloroquine alone, at the concentrations (T4 in Fig. 6B and data not shown). CpG DNA induced used in the experiment, did not affect these mRNAs in WEHIfurther activation of NFκB in splenic B cells which was 231 cells (Fig. 5A and B) .
rapid (within 15 min after stimulation) and sustained ( Fig.  6B and data not shown). Control non-CpG DNA failed to Chloroquine blocks CpG DNA-induced NFκB activation in induce NFκB activation in splenic B cells (Fig. 6B) .
WEHI-231 cells and primary splenic B cells
Like CpG DNA, anti-CD40 also induced further nuclear The transcription factor NFκB has an important role in translocation of NFκB in primary splenic B cells (Fig. 6B) . regulating several proto-oncogenes including c-myc.
Addition of chloroquine completely abolished CpG DNABecause CpG DNA rapidly induces nuclear translocation of mediated NFκB activation in splenic B cells. In contrast, NFκB in WEHI-231 cells (27) , we addressed the unanswered neither the basal NFκB activation nor the anti-CD40-induced questions of whether CpG DNA can also induce nuclear activation of NFκB in splenic B cells were affected by the translocation of NFκB in splenic B cells, and whether chlorosame concentration of chloroquine (Fig. 6B) . quine has any effect on the CpG DNA-induced NFκB activation in either WEHI-231 cells or primary splenic B cells. As Discussion previously demonstrated (27, 35) , within 8 h after stimulation with anti-IgM, the levels of NFκB p50/c-Rel heterodimer Recent studies have demonstrated that CpG motifs in bacterial DNA induce polyclonal B cell activation, and block apoptosis declined while the levels of p50/p50 homodimer, which acts Table 1 ). These results suggest that CpG DNA may induce growth in splenic B cells and WEHI-231 cells, and rescue them from apoptosis through pathways sharing a chloroquineinhibitable step. The inhibitory effects of chloroquine at low concentrations were very selective for CpG DNA-mediated protection, failing to inhibit LPS-or CD40-mediated cell proliferation and apoptosis protection (Figs 1 and 2 , Table  1 , and data not shown). However, higher concentrations (Ͼ20 µM) of chloroquine not only inhibited the mitogenic and anti-apoptotic abilities of LPS or CD40 in splenic B cells and WEHI-231 cells, but also induced cell death (data not shown). A recent study showed that chloroquine and several of its chemical analogues, including some used as anti-malarial drugs, inhibited CpG DNA-mediated rescue of WEHI-231 cells from anti-IgM-induced apoptosis (29) . However, the molecular mechanism by which these drugs inhibit CpG DNAmediated protection against anti-IgM-induced apoptosis of WEHI-231 cells was not studied.
Reduction of the ψm, which involves the opening of permeability transition pores in the mitochondrial membrane, is thought to be a point-of-no-return in the apoptosis cascade (34) . Whether this ψm loss takes place during the spontaneous apoptosis of splenic B cells had not been examined previously. (Fig. 3 and data not shown) . Previously, we have identified several proto-oncogenes and (1 µg/ml) for 4 h. Cells were then harvested and nuclear extracts oncoproteins up-regulated by CpG DNA, which are potentially were prepared as described (27) . Equal concentrations (3 µg/lane) of nuclear protein were analyzed for NFκB activation using EMSA. A related to CpG DNA-mediated cell cycle entry and protection 32 P-labeled oligonucleotide containing the κ-intronic enhancer (5Ј-against spontaneous apoptosis in primary splenic B cells, GTAGGGGACTTTCCGAGCTCGAGATCCTATG-3Ј) was used as a and protection against anti-IgM-induced growth arrest and probe. The experiment was repeated 3 times with similar results. apoptosis of WEHI-231 cells (9,26). Our recent studies have also shown that chloroquine at concentrations Ͻ5 µM effectively inhibits CpG DNA-induced cytokine gene expression and protein production in murine B cell and monocytic cell in splenic B cells and the B cell line WEHI-231 (9,26,27).
lines (28) . These results suggested that chloroquine might Since apoptosis is thought to be important in maintaining abolish CpG DNA-mediated cell growth and apoptosis protecimmune tolerance to self-antigens, these findings are tion by suppressing the CpG DNA-induced expression of this compatible with the hypothesis that bacterial infection may same set of proto-oncogenes in splenic B cells or WEHI-231 potentiate autoimmune diseases such as SLE (39) . Chlorocells. Indeed, low concentrations of chloroquine selectively quine has been used empirically as a therapeutic agent for inhibited CpG DNA-induced expression of c-Myc, c-Jun, Bclautoimmune diseases such as lupus and rheumatoid arthritis x L and Bax mRNA and protein in both splenic B cells and without knowing its exact mechanisms of action. In the present WEHI-231 cells (Figs 4 and 5, and data not shown). However, study, we showed that chloroquine inhibits several of the B even though other anti-apoptotic agents, such as anti-CD40 cell-activating effects of CpG DNA and examined candidate and LPS, closely resembled CpG DNA in their effects on molecules likely to mediate CpG DNA action for sensitivity to oncogene and oncoprotein expression, low concentrations of chloroquine.
chloroquine failed to block proto-oncogene expression or As previously reported, CpG DNA induced cell cycle entry oncoprotein production induced by them in the same cells, and protected splenic B cells from spontaneous apoptosis indicating the specific action of this drug on the CpG DNA-( Fig. 2A and B Table  results indicate that CpG DNA induces expression of proto-1) (26,27). Very low concentrations of chloroquine (Ͻ5 µM) oncogenes and oncoproteins, directly and/or indirectly effectively abolished these CpG DNA-mediated effects in both splenic B cells and WEHI-231 cells (Figs 1 and 2 , and involved in cell growth and/or survival, through a chloroquine-sensitive pathway, which at some proximal point is distinct require much higher doses of chloroquine (Ͼ1 mM) than those we used to inhibit CpG DNA function in this study from the anti-CD40-or LPS-mediated signaling pathways.
CpG DNA rapidly induces degradation of IκBα and IκBβ (ഛ5 µM). Chloroquine can modulate intracellular Ca 2ϩ flux (50), but we failed to detect any increases in the intracellular and subsequent translocation of NFκB in B cell lines and macrophage/monocyte-like cell lines (27, 28, 40, 41) . Sustained Ca 2ϩ level within 10 min after stimulation with CpG DNA in WEHI-231 or J774 cells (Krieg, et al., unpublished data) . NFκB activation in WEHI-231 cells has been proposed to play a key role in the CpG DNA-mediated protection against antiChloroquine reportedly exerts an antioxidant effect and can influence the generation of ROS in leukocytes (51) . CpG DNA IgM-induced growth arrest and apoptosis (27) , but a similar role for NFκB in the CpG DNA-mediated effects on primary induces intracellular generation of ROS, a critical mediator in CpG DNA-mediated signaling pathway (12,28). In theory, splenic B cells had not been investigated previously. We found NFκB to be highly activated in the freshly isolated such an antioxidant effect of chloroquine could explain the inhibitory effects of chloroquine on CpG DNA-mediated primary splenic B cells, but DNA binding activity of NFκB gradually decreased after onset of culture (Fig. 6B and data immune activation. However, the concentrations of chloroquine that influence the ROS generation in leukocytes (20-not shown). These changes in the NFκB DNA binding activity in splenic B cells during in vitro culture correspond to the 100 µM) are markedly higher than those used in this study (ഛ5 µM). Moreover, at this low concentration, chloroquine changes in the level of c-Myc mRNA and protein which might play an important role in splenic B cell growth and survival selectively inhibits CpG DNA-induced intracellular generation of ROS, but not that induced by other anti-or pro-apoptotic (Fig. 4 and data not shown) (9). In addition, recent studies have demonstrated that NFκB regulates the expression of the agents including LPS, anti-CD40, and anti-IgM (28) . This study indicates that the inhibitory effects of chloroquine on proto-oncogene c-myc, and that sustained NFκB activation and subsequent c-myc expression prevent WEHI-231 cells CpG DNA-mediated apoptosis protection and other immune activation are not due to its antioxidant effect but may be due from undergoing apoptosis (27, 37, 42) . Interestingly, all antiapoptotic agents we tested including CpG DNA rapidly to inhibition of more proximal step(s) in the CpG DNAmediated signaling pathway. Chloroquine increases pH within induced sustained NFκB activation and c-Myc expression in primary splenic B cells (Figs 4 and 6 , and data not shown), intracellular vacuoles, including endosomes, lysosomes and Golgi apparatus, and alters processes such as protein suggesting the importance of sustained NFκB activation and c-Myc expression in the survival as well as the growth of degradation, assembly of macromolecules and post-translational modification of proteins in those organelles (reviewed in splenic B cells. Indeed, blocking of NFκB activation by the inhibitors SN50 and gliotoxin abolished anti-apoptotic effects 45). Indeed, high concentrations (100-250 µM) of chloroquine inhibit LPS-induced production of TNF-α by altering intraof CpG DNA or other anti-apoptotic agents in splenic B cells (Yi et al. , manuscript in preparation). Moreover, chloroquine, cellular processing of TNF-α without affecting the LPS-mediated NFκB activation or mRNA expression (51) . As shown in which selectively inhibits CpG DNA-mediated apoptosis protection, blocked only CpG DNA-mediated NFκB activation, this and our previous studies, the inhibitory effects of low concentrations of chloroquine on CpG DNA-mediated but failed to block LPS-or anti-CD40-induced NFκB activation, in both splenic B cells and WEHI-231 cells (Figs 6A and 6B) . apoptosis protection and other immune activation events take place at more proximal steps in the signaling pathway Our results support the recent findings of other investigators that NFκB activation is a key factor for apoptosis protection than intracellular processing of protein (28, 44) . Our recent data suggests that CpG DNA is taken up by cells via in B and monocytic cells (27, 37, 42, 43) .
The earliest steps in the CpG DNA-mediated signaling endocytosis (52) , and that endosomal acidification of DNA is required for CpG DNA-mediated signaling (28) . Therefore, it pathway we have identified so far are intracellular ROS generation, NFκB and AP-1 activation, and c-Jun-N-terminal seems more probable that chloroquine blocks CpG DNAmediated signaling by raising endosomal pH, resulting in kinase and p38 kinase activation (12, 28, 40, 44) . Chloroquine inhibits activation of all of these CpG DNA-mediated intrainhibition of endosomal processing of DNA or of release of DNA from the endosome. CpG DNA does not appear to have cellular signaling pathways in B lymphoma and monocytic cell lines (28, 44) , indicating that chloroquine acts at an even any sequence-specific membrane receptor. However, there are sequence-specific CpG DNA receptor(s) (CpGBP) in both more proximal step in this CpG DNA-mediated signaling pathway, but its mechanism remains unclear. Because of its cytosol and nuclei of B cells and monocytic cells (Tuetken et al., unpublished data). Chloroquine did not inhibit the beneficial effects on treatments of rheumatoid arthritis and SLE, numerous efforts have been made to explore potential binding activity of CpGBP to CpGDNA in vitro (data not shown). However, the impact of chloroquine on the binding mechanisms of action of chloroquine (reviewed in 45). Since immune activation by CpG DNA requires cellular uptake of of CpG DNA to CpGBP in vivo and downstream signaling cascades remain to be explored. Regardless of its exact the DNA (11), it is possible that chloroquine might block the DNA uptake by the cell. However, we could not detect any mechanism of action, it is important to point out that all of the previously reported effects of chloroquine on the inhibition of cellular uptake of DNA by chloroquine using flow cytometry analysis (data not shown). Chloroquine could modulation of the immune system required higher drug levels (20-100 µM) than those found when chloroquine is used to intercalate into DNA (46) and block the function of CpG DNA. However, this also seems not to explain the inhibition of CpG treat arthritis or SLE patients (whole blood levels~5 µM) (reviewed in 45). In contrast, concentrations of chloroquine DNA action based on a recent report by other investigators (29) . Chloroquine also has been reported (47) (48) (49) to inhibit which inhibit CpG DNA-mediated apoptosis protection and other immune activation including cytokine production in vitro phospholipase A1 and phospholipase A2, but these effects
